Chang, Jenny C.

Cancer stem cells: Role in tumor growth, recurrence, metastasis, and treatment resistance

Chang, J. C. (2016) · Medicine

Cancer Cells and MetastasisMesenchymal stem cell research

Cited by 435

Loss of phosphatase and tensin homolog or phosphoinositol-3 kinase activation and response to trastuzumab or lapatinib in human epidermal growth factor receptor 2-overexpressing locally advanced breast cancers

Dave, B., Migliaccio, I., Gutierrez, M. C., Wu, M.-F., Chamness, G. C., Wong, H., Narasanna, A., Chakrabarty, A., Hilsenbeck, S. G., Huang, J., et al. (2011) · Journal of Clinical Oncology

HER2/EGFR in Cancer ResearchPI3K/AKT/mTOR signaling in cancer

Cited by 252

Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition

Rexer, B. N., Ham, A.-J. L., Rinehart, C., Hill, S., de Matos Granja-Ingram, N., González-Angulo, A. M., Mills, G. B., Dave, B., Chang, J. C., Liebler, D. C., et al. (2011) · Oncogene

HER2/EGFR in Cancer ResearchLung Cancer Treatments and Mutations

Cited by 139

Vitamin E enhances cancer immunotherapy by reinvigorating dendritic cells via targeting checkpoint SHP1.

Yuan, X., Duan, Y., Xiao, Y., Sun, K., Qi, Y., Zhang, Y., Ahmed, Z., Moiani, D., Yao, J., Li, H., et al. (2022) · Cancer Discovery

Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers

Cited by 130

Trastuzumab-resistant cells rely on a HER2-PI3K-FoxO-survivin axis and are sensitive to PI3K inhibitors

Chakrabarty, A., Bhola, N. E., Sutton, C., Ghosh, R., Kuba, M. G., Dave, B., Chang, J. C., & Arteaga, C. L. (2013) · Cancer Research

HER2/EGFR in Cancer ResearchPI3K/AKT/mTOR signaling in cancer

Cited by 130

Analysis of the Implementation of Telehealth Visits for Care of Patients With Cancer in Houston During the COVID-19 Pandemic

Darcourt, J. G., Aparicio, K., Dorsey, P. M., Ensor, J. E., Zsigmond, E. M., Wong, S. T., Ezeana, C. F., Puppala, M., Heyne, K. E., Geyer, C. E., et al. (2021) · JCO Oncology Practice

Telemedicine and Telehealth ImplementationCOVID-19 and healthcare impacts

Cited by 114

Cancer therapeutic targeting using mutant–p53-specific siRNAs

Ubby, I., Krueger, C., Rosato, R., Qian, W., Chang, J., & Sabapathy, K. (2019) · Oncogene

Cancer-related Molecular PathwaysRNA Interference and Gene Delivery

Cited by 50